IQVIA HOLDINGS INC. (IQV) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-03-31..
Dividend safety
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | 1.39B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-03-31 | (m) | $1.39B | (m) |
| 2025-12-31 | (m) | $1.36B | (m) |
| 2025-09-30 | (m) | $1.28B | (m) |
| 2025-06-30 | (m) | $1.24B | (m) |
| 2025-03-31 | (m) | $1.33B | (m) |
| 2024-12-31 | (m) | $1.37B | (m) |
| 2024-09-30 | (m) | $1.41B | (m) |
| 2024-06-30 | (m) | $1.42B | (m) |
| 2024-03-31 | (m) | $1.36B | (m) |
| 2023-12-31 | (m) | $1.36B | (m) |
| 2023-09-30 | (m) | $1.12B | (m) |
| 2023-06-30 | (m) | $1.10B | (m) |
| 2023-03-31 | (m) | $1.05B | (m) |
| 2022-12-31 | (m) | $1.09B | (m) |
| 2022-09-30 | (m) | $1.18B | (m) |
| 2022-06-30 | (m) | $1.16B | (m) |
| 2022-03-31 | (m) | $1.08B | (m) |
| 2021-12-31 | (m) | $966.00M | (m) |
| 2021-09-30 | (m) | $767.00M | (m) |
| 2021-06-30 | (m) | $607.00M | (m) |
| 2021-03-31 | (m) | $409.00M | (m) |
| 2020-12-31 | (m) | $279.00M | (m) |
| 2020-09-30 | (m) | $176.00M | (m) |
| 2020-06-30 | (m) | $132.00M | (m) |
| 2020-03-31 | (m) | $215.00M | (m) |
| 2019-12-31 | (m) | $191.00M | (m) |
| 2019-09-30 | (m) | $244.00M | (m) |
| 2019-06-30 | (m) | $247.00M | (m) |
| 2019-03-31 | (m) | $248.00M | (m) |
| 2018-12-31 | (m) | $259.00M | (m) |
| 2018-09-30 | (m) | $1.25B | (m) |
| 2018-06-30 | (m) | $1.28B | (m) |
| 2018-03-31 | (m) | $1.28B | (m) |
| 2017-12-31 | (m) | $1.31B | (m) |
| 2017-09-30 | (m) | $55.00M | (m) |
| 2017-06-30 | (m) | $71.00M | (m) |
| 2017-03-31 | (m) | $82.00M | (m) |
| 2016-12-31 | (m) | $115.00M | (m) |
| 2016-09-30 | (m) | $397.16M | (m) |
| 2016-06-30 | (m) | $409.28M | (m) |
| 2016-03-31 | (m) | $407.48M | (m) |
| 2015-12-31 | (m) | $387.20M | (m) |
| 2015-09-30 | (m) | $371.06M | (m) |
| 2015-06-30 | (m) | $352.43M | (m) |
| 2015-03-31 | (m) | $352.60M | (m) |
| 2014-12-31 | (m) | $356.38M | (m) |
| 2014-09-30 | (m) | $340.95M | (m) |
| 2014-06-30 | (m) | $315.07M | (m) |
| 2014-03-31 | (m) | $268.46M | (m) |
| 2013-12-31 | (m) | $226.59M | (m) |
| 2013-09-30 | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) |
| 2012-12-31 | (m) | $177.55M | (m) |
| 2012-09-30 | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) |
| 2011-12-31 | (m) | $241.77M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |